Therapeutic area segments performance in the global cancer supportive care market

The global cancer supportive care market is expected to grow at a CAGR of 3.84% during the forecast period. Based on therapeutic area, the global cancer supportive care market has been segmented into chemotherapy-induced anemia, chemotherapy-induced neutropenia, cancer pain, CINV, and others.

Anemia is one of the most common types of side effects faced by individuals undergoing cancer treatment. Almost all individuals going through chemotherapy suffer mild anemia, and more than three-fourth of them develop more severe problems. Although the popularity of chemotherapy has been reducing in developed countries, it remains the first line of treatment in developing countries owing to chemotherapy’s deep penetration in the region.

Request for: Free Sample Report

As the cancer cases are rising in developing countries as well, the higher adoption rate of chemotherapy will increase the demand for drugs indicated for chemotherapy-induced anemia. Despite a lesser preference for chemotherapy as a cancer treatment in developed countries, it remains one of the leading therapies in those regions to kill cancer cells. As the destruction of bone marrow is certain post-chemotherapy, the cases of anemia will rise in developed countries as well, thereby, driving the global cancer supportive care market growth during the forecast period.